Jan 04, 2024 / 04:00PM GMT
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Welcome to 2024. Anyway, my name is Chris Shibutani. I'm a member of the Goldman Sachs health care team. We are deeply grateful for the teams that were able to join us for this conference this very early date this year, and obviously, the point is to try and give voice and an opportunity to talk about some of the most interesting and intriguing stories across the health care landscape ahead of next week's confab. I am especially pleased to once again be able to be joined on stage by Adam Lenkowsky who recently got a promotion to Chief Commercialization Officer from your role previously. So Adam, thank you very much for joining us.
Adam Lenkowsky - Bristol-Myers Squibb Company - Executive VP, Chief Commercialization Officer & Head of U.S. Oncology
Thank you, Chris. Happy New Year.
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Yes, indeed. And especially appreciative to the IR team as well, Tim Power
Bristol-Myers Squibb Co at Goldman Sachs Healthcare C-Suite Unscripted Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers